Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Surface Oncology Inc (NQ: SURF )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.030 (21)
Ask (Size) 1.090 (10)
Prev. Close 1.070
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 45,452,450
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the September 7th Special Meeting 
From Surface Oncology, Inc.
Via GlobeNewswire
SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

More News

Read More
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
From Surface Oncology, Inc.
Via GlobeNewswire
Health Care Company Coherus BioSciences Announces Merger With Surface Oncology
Via Benzinga
Recap: Surface Oncology Q1 Earnings
Via Benzinga
Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares
Via Benzinga
Cathie Wood's Ark Pours $3.3M More Into This Chipmaker Amid AI Frenzy: Here Are Other Major Monday Trades
Via Benzinga
Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made
Via Benzinga
Cathie Wood Sells $7M Tesla Stock Friday Amid Pullback, Bets Big On This Crypto-Linked Stock
Via Benzinga
SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF
From Kahn Swick & Foti, LLC
Via Business Wire
Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability
Via Benzinga
Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June
Via Benzinga
Crude Oil Rises; Adobe Posts Upbeat Results
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
Via Benzinga
Coherus BioSciences, MicroVision, Millicom And Other Big Stocks Moving Lower On Friday
Via Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
SURF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surface Oncology, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
US Stocks Mixed; Dow Gains 50 Points
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M
Via Benzinga
Coherus to Acquire Surface Oncology
From Surface Oncology, Inc.
Via GlobeNewswire
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
From Surface Oncology, Inc.
Via GlobeNewswire
Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023
From Surface Oncology, Inc.
Via GlobeNewswire
Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023
From Surface Oncology, Inc.
Via GlobeNewswire
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022
From Surface Oncology, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.